However, the healthcare giant beat Wall Street expectations in earnings and revenue in the fourth quarter, sending CVS stock ...

CVS Health plans to shed enrollment by more than 1 million members this year, mostly in Medicare Advantage and individual ...

CEO David Joyner highlighted the company's Q4 adjusted EPS of $1.19 and adjusted operating income of $2.7 billion. He introduced 2025 adjusted EPS guidance of $5.75 to $6.00, emphasizing recovery in ...

CVS Health reported $4.6 billion in 2024 profit including $1.6 billion in the fourth quarter as its health insurance business ...

CVS Health (CVS) stock was upgraded by Cantor Fitzgerald to Overweight after the company posted strong Q4 results earlier in ...

CVS is trying to turn around its drugstore chain and insurance business. The company spent a smaller percentage of premium ...

CVS Health’s total revenue for the full year 2024 increased 4.2% to $372.8 billion, but within the healthcare benefits ...

Says Healthcare Benefits business has biggest opportunity for outperformance in 2025. Says Medicare Advantage business positioned well, strong ...

CVS Health reported Q4 2024 profits of $1.6 billion, down from $2 billion, with annual profits at $4.6 billion, down $8.3 billion in 2023.

When it comes to high drug costs for consumers, pharmacy benefit managers are not the villains, the new CVS chief executive said Wednesday.

Operator Good morning, and thank you all for attending the CVS Health Q4 2024 earnings conference call. My name is Brika, and I will be your moderator for today's call. [Operator instructions] I would ...

CVS Health steered through rising costs in its insurance division to handily beat profit expectations on Wall Street.